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Background: Intracranial involvement is an uncommon manifestation of Rosai–Dorfman
disease (RDD) and had been rarely reported. In this study, we explore clinical characteristics,
imageology manifestations and pathological features of primary intracranial RDD so as to
improve the understanding for this disease.
Methods: One case (16-years-old boy) with primary intracranial RDD was analyzed and
studied retrospectively by MRI features, histopathological observation and immunohisto-
chemical staining, and the related literatures were reviewed.
Results: The case was single lesion and involved the dura of the left middle cranial fossa base,
which was iso-hypo signal intensity on T1WI and hypointense on T2WI and FLAIR image. The
lesion was a homogeneous contrast enhancement mass with dural tail sign and had peri-
tumoral brain edema. Pathological analysis showed the lesion consisted of variable numbers
of mature lymphocytes, plasma cells and neutrophils. The characteristic histiocytes were
emperipolesis and positively expressed for S-100 and CD-68 and negatively expressed for CD-
1a by immunohistochemical analysis. Based on clinical presentations and histological ﬁnd-
ings after surgical excision, a ﬁnal diagnosis of primary intracranial RDD was made.
Conclusion: Primary intracranial RDD, especially located in the cranial base, is exceptionally
rare, which hard to be distinguished with meningoma by imageology and clinical manifes-
tations, but could be diagnosed by pathological and immunohistochemical examinations.
Surgery is of the most importance treatment and prognosis is optimistic for this disease.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Rosai–Dorfman disease (RDD), also known as sinus histiocy-
tosis with massive lymphadenopathy (SHML), which is an* Corresponding author at: Department of Neurosurgery, The Afﬁliate
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nodes, and was ﬁrst described by Lucien Destombes in 1965
and was recognized as a distinct clinicopathologic entity by
Rosai and Dorfman in 1969 [1]. Although extranodal involve-
ment has been reported in diverse sites, intracranial presen-
tation of this disease is extremely rare.d Nanping First Hospital of Fujian Medical University, The First
0, China.
297400286@qq.com ().
p. z o.o. All rights reserved.
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And it was basically occurred in adults. In this article, we
described a 16-years-old boy who had an isolated intracranial
involvement of RDD. The current literatures and treatment
options were also reviewed.
2. Case report
A 16-years-old boy, without a signiﬁcant past history, presented
with a generalized tonic-clonic seizure. He was admitted to our
neurosurgery department for an abrupt onset of tremor andFig. 1 – Brain MRI with contrast showed the enhancing lesion and
be iso-hypointense (D), and T2 (E–G) and FLARE (H) predominan
circular hyperintense surrounding lesion and very hypointense 
homogeneously hyper-dense lesion without any internal calcific
(M). Hyperplasia and destruction of skull base bone were seen ac
MRI of the brain showed total excision of the lesion (J, K) and wjerking of his Limbs, lock-jaw and loss of consciousness. For
about 3 min, he gradually regained consciousness. After the
attack, he also complained of dizziness, headache and
weakness. He had never experienced this symptom before.
His family history was negative for tumors. The neurological
examination showed no abnormalities.
Brain MRI showed a homogenous contrast enhancement
mass measured approximately 3.3*3.2*1.2 cm and enhancing
dura tail in the left temporal fossa region (Fig. 1A–C). T1-
weighted MRI revealed the lesion to be iso-hypointense
(Fig. 1D), and T2 (Fig. 1E–G) and FLARE (Fig. 1H) predominant
hypointense and perilesion edema. DWI also showed circular the dural tail (A–C). T1 weighted MRI revealed the lesion to
t hypointense and perilesion edema. DWI also showed
for lesion (I). Non-contrast axial CT scan showed a
ations and hemorrhage in the left middle cranial fossa base
cording to three-dimensional CT scan (N–P). Post-operative
ithout evidence of recurrence after 5 years of follow-up (L).
Fig. 2 – Microscopically, section showed infiltration of abundant lymphocytes, plasma cells and neutrophils, and some
histiocytes scattered in fibrotic background. Histiocytic cells occasionally showed emperipolesis with intact lymphocytes,
plasma cells and neutrophils (A, B, H&E, 400T). On immunohistochemical examination, histiocytes are positive for S-100 (C)
and CD68 (D) (400T), but negative for CD1a.
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lesion (Fig. 1I). Axial plain CT scan showed a lesion which was
relatively hyperdense located in the left skull base, and no
evidence of any calciﬁcation and hemorrhage was observed
within (Fig. 1M). Hyperplasia and destruction of skull base
bone were seen according to three-dimensional CT scan
(Fig. 1N–P).
Electroencephalogram did not show typical diffuse spike
and slow waves activity. Blood examinations, Urine test, CSF
analysis and others test were also normal.
The patient underwent craniotomy and total resection of
the lesion. During the surgery, the tumor was gray-white, well-
circumscribed, relatively avascular and tough in consistency.
There was no clear arachnoid boundary between the lesion
and the cortex, and the tumor tightly adhered to brain
parenchyma and skull.
Histologic examinations showed that proliferation of
histiocytic cells and inﬁltration of lymphocytes, plasma cells
and neutrophils were seen (Fig. 2A and B). Immunohisto-
chemical stainings were strongly positive for S-100 (Fig. 2C),
CD68 (Fig. 2D), Vimentin, Kappa and Lambda, but negative for
CD1a, CD30, EMA, and GFAP, and Ki67 less than 5%.
Based on these ﬁndings above, thus the ﬁnal diagnosis was
RDD. Post-operative MRI showed total excision of the lesion(Fig. 1J and K). After 5 years of follow-up, the patient was well and
asymptomatic, without clinical evidence of recurrence (Fig. 1L).
3. Discussion
RDD often involve lymph nodes, and the most common
extranodal sites are skin, nasal cavity, paranasal sinus, eyelid,
orbit, bone, salivary gland and CNS. Although extranodal
involvement has been reported in diverse sites, primary
isolated intracranial RDD without lymphadenopathy is ex-
tremely rare (less than 5% of RDD) [2]. In the available
literatures, approximately 75% of CNS RDD is intracranial,
whereas less involve the spine [3]. Occasionally, simultaneous
involvement of the brain and spinal cord had also been
described [3]. Patients with intracranial involvement usually
present with headache and seizures. They can also present
with dysphasia, cranial nerve deﬁcit, hemiparesis, and
endocrine dysfunction mainly depending on the location
and size of the lesion. The precise etiology, pathogenesis, and
natural history of RDD are still unknown. Although researches
revealed some underlying association between RDD and
bacteria, virus and immune dysfunction, a deﬁnitive agent
has never been isolated [4,5].
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very similar to that of meningioma, thus it is the most easily to
be diagnosed as meningioma according to MRI. On MRI,
although the image is uncharacteristic, the typical appearance
is a dura-based homogeneously enhancing mass, which is
associated with peritumoral edema and having a dural tail,
iso-hypointense on T1-weighted images and isointensity or
very low signal intensity on T2-weighted images [6]. These MRI
features may help us to differentiate RDD lesions from the
meningiomas. Our case presented as a meningioma-like,
extra-parenchymal, dural-based mass, which also had very
low signal intensity areas on T2-weighted and FLAIR images
on MRI. The lesion was smaller, but the peritumoral edema
was remarkable.
The histopathologic differential diagnosis includes lympho-
ma, plasma cell granuloma, Langerhans cell histiocytosis (LCH)
and plasma cell rich meningioma. In our case, considering the
lack of atypical lymphocytes, lymphoma was unlikely. Because
of the presence of emperipolesis, plasma cell granuloma could
be excluded. LCH was also unlikely, because Langerhans
histiocytes with their folded nuclei and eosinophil inﬁltrates
were absent, and the CD1a was negative in the tumor.
Radiologically, contrast enhancement and perilesional edema
are common to both lymphoplasmacyte-rich meningiomas and
RDD, but S100 and EMA are positivity in the plasma cell rich
meningioma [7]. In view of these possibilities, histological and
immunohistochemical examinations are essential for a deﬁni-
tive diagnosis of RDD. In addition, the presence of emperipolesis
is a hallmark of the disease, even if this may be less marked in
intracranial disease [8]. In our case, the ﬁndings of emperipol-
esis, positivity for CD68 and S100 and negativity for CD1a were
coherent with the diagnosis of RDD.
There are no speciﬁc treatment guidelines for intracranial
RDD. Although a variety of treatment methods have been
used, including steroid therapy, chemotherapeutic agents and
radiation, surgical resection appeared to be the most appro-
priate choice [3,9,10]. When surgical excision is not possible
and recurrence or residual after surgery, adjuvant therapy
such as local low dose radiotherapy and steroids can be used.
Prognosis of the disease is optimistic, and no death was
reported. Our patient, who had a single operation for the total
resection of the lesion and did not receive any further therapies,
was followed up over a period of 5 years and had no recurrent.
4. Conclusions
In summary, we provide detailed information for intracranial
RDD. Despite intracranial RDD is uncommon, more attention
should be given.
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